| Substance | Condition | Seq | Src | PMID | Dtl | Title |
| Cannabidiol | Alzheimer's Disease | 35 | PM | 38785534 | 📋 | Modulation of Oxidative Stress and Neuroinflammation by Cannabidiol (CBD): Promising Targets for the Treatment of Alzheimer's Disease |
| Cannabidiol | Alzheimer's Disease | 34 | PM | 38590254 | 📋 | Cannabidiol improves the cognitive function of SAMP8 AD model mice involving the microbiota-gut-brain axis |
| Cannabidiol | Alzheimer's Disease | 33 | PM | 38067101 | 📋 | Assessing Cannabidiol as a Therapeutic Agent for Preventing and Alleviating Alzheimer's Disease Neurodegeneration |
| Cannabidiol | Alzheimer's Disease | 32 | PM | 37959001 | 📋 | An In Silico Study for Expanding the Utility of Cannabidiol in Alzheimer's Disease Therapeutic Development |
| Cannabidiol | Alzheimer's Disease | 31 | PM | 37892128 | 📋 | The Main Therapeutic Applications of Cannabidiol (CBD) and Its Potential Effects on Aging with Respect to Alzheimer's Disease |
| Cannabidiol | Alzheimer's Disease | 30 | PM | 37602231 | 📋 | Synergetic effect of β-asarone and cannabidiol against Aβ aggregation in vitro and in vivo |
| Cannabidiol | Alzheimer's Disease | 29 | PM | 36544841 | 📋 | The gut microbiota in neurodegenerative diseases: revisiting possible therapeutic targets for cannabidiol |
| Cannabidiol | Alzheimer's Disease | 24 | PM | 36238565 | 📋 | Effect of long-term cannabidiol on learning and anxiety in a female Alzheimer's disease mouse model |
| Cannabidiol | Alzheimer's Disease | 23 | PM | 35628181 | 📋 | Cannabidiol Enhances Microglial Beta-Amyloid Peptide Phagocytosis and Clearance via Vanilloid Family Type 2 Channel Activation |
| Cannabidiol | Alzheimer's Disease | 28 | PM | 35385645 | 📋 | Effect of Cannabidiol on the Neural Glyoxalase Pathway Function and Longevity of Several C. elegans Strains Including a C. elegans Alzheimer's Disease Model |
| Cannabidiol | Alzheimer's Disease | 27 | PM | 35202719 | 📋 | Cannabidiol (CBD) treatment improves spatial memory in 14-month-old female TAU58/2 transgenic mice |
| Cannabidiol | Alzheimer's Disease | 26 | PM | 35181336 | 📋 | Cannabidiol protects against Alzheimer's disease in C. elegans via ROS scavenging activity of its phenolic hydroxyl groups |
| Cannabidiol | Alzheimer's Disease | 25 | PM | 35163003 | 📋 | Cannabidiol Treatment Improves Glucose Metabolism and Memory in Streptozotocin-Induced Alzheimer's Disease Rat Model: A Proof-of-Concept Study |
| Cannabidiol | Alzheimer's Disease | 22 | PM | 34944028 | 📋 | Cannabidiol Inhibits Tau Aggregation In Vitro |
| Cannabidiol | Alzheimer's Disease | 21 | PM | 34573232 | 📋 | Understanding the Modulatory Effects of Cannabidiol on Alzheimer's Disease |
| Cannabidiol | Alzheimer's Disease | 20 | PM | 33817834 | 📋 | Cannabidiol regulates CB1-pSTAT3 signaling for neurite outgrowth, prolongs lifespan, and improves health span in Caenorhabditis elegans of Aβ pathology models |
| Cannabidiol | Alzheimer's Disease | 19 | PM | 33797364 | 📋 | Roles of Cannabidiol in the treatment and prevention of Alzheimer's disease by multi-target actions |
| Cannabidiol | Alzheimer's Disease | 18 | PM | 33096116 | 📋 | Cannabidiol (CBD) enhanced the hippocampal immune response and autophagy of APP/PS1 Alzheimer's mice uncovered by RNA-seq |
| Cannabidiol | Alzheimer's Disease | 17 | PM | 32640965 | 📋 | Impact of Cannabis-Based Medicine on Alzheimer's Disease by Focusing on the Amyloid β- Modifications: A Systematic Study |
| Cannabidiol | Alzheimer's Disease | 9 | PM | 32210795 | 📋 | From Cannabis sativa to Cannabidiol: Promising Therapeutic Candidate for the Treatment of Neurodegenerative Diseases |
| Cannabidiol | Alzheimer's Disease | 2 | PM | 29574668 | 📋 | Cannabidiol Reverses Deficits in Hippocampal LTP in a Model of Alzheimer's Disease |
| Cannabidiol | Alzheimer's Disease | 8 | PM | 28981597 | 📋 | Effects of Cannabidiol Interactions With Wnt/β-catenin Pathway and PPARγ on Oxidative Stress and Neuroinflammation in Alzheimer's Disease |
| Cannabidiol | Alzheimer's Disease | 11 | PM | 28412918 | 📋 | Neurological Aspects of Medical Use of Cannabidiol |
| Cannabidiol | Alzheimer's Disease | 15 | PM | 28217094 | 📋 | In vivo Evidence for Therapeutic Properties of Cannabidiol (CBD) for Alzheimer's Disease |
| Cannabidiol | Alzheimer's Disease | 12 | PM | 28025562 | 📋 | Cannabidiol Modulates the Expression of Alzheimer's Disease-Related Genes in Mesenchymal Stem Cells |
| Cannabidiol | Alzheimer's Disease | 16 | PM | 27471947 | 📋 | The Therapeutic Potential of the Phytocannabinoid Cannabidiol for Alzheimer's Disease |
| Cannabidiol | Alzheimer's Disease | 7 | PM | 27137221 | 📋 | Pharmacological Management of Agitation and Aggression in Alzheimer's Disease: A Review of Current and Novel Treatments |
| Cannabidiol | Alzheimer's Disease | 5 | PM | 27110749 | 📋 | Natural Phytochemicals in the Treatment and Prevention of Dementia: An Overview |
| Cannabidiol | Alzheimer's Disease | 3 | PM | 25125475 | 📋 | Cannabis-based Medicine Reduces Multiple Pathological Processes in AβPP/PS1 Mice |
| Cannabidiol | Alzheimer's Disease | 4 | PM | 17592514 | 📋 | Cannabidiol in Vivo Blunts Beta-Amyloid Induced Neuroinflammation by Suppressing IL-1beta and iNOS Expression |
| Cannabidiol | Alzheimer's Disease | 13 | PM | 16490313 | 📋 | Cannabidiol Inhibits Inducible Nitric Oxide Synthase Protein Expression and Nitric Oxide Production in Beta-Amyloid Stimulated PC12 Neurons Through p38 MAP Kinase and NF-kappaB Involvement |
| Cannabidiol | Alzheimer's Disease | 14 | PM | 16389547 | 📋 | The Marijuana Component Cannabidiol Inhibits Beta-Amyloid-Induced Tau Protein Hyperphosphorylation Through Wnt/beta-catenin Pathway Rescue in PC12 Cells |
| Cannabidiol | Alzheimer's Disease | 10 | PM | 15728830 | 📋 | Prevention of Alzheimer's Disease Pathology by Cannabinoids: Neuroprotection Mediated by Blockade of Microglial Activation |
| Cannabidiol | Alzheimer's Disease | 6 | PM | 15030397 | 📋 | Neuroprotective Effect of Cannabidiol, a Non-Psychoactive Component From Cannabis Sativa, on Beta-Amyloid-Induced Toxicity in PC12 Cells |
| Cannabidiol | Alzheimer's Disease | 1 | PM | 9309469 | 📋 | Effects of Dronabinol on Anorexia and Disturbed Behavior in Patients With Alzheimer's Disease |
| Cannabidiol | Dementia | 5 | PM | 30616019 | 📋 | Blood-brain Barrier Disturbances in Diabetes-Associated Dementia: Therapeutic Potential for Cannabinoids |
| Cannabidiol | Dementia | 3 | PM | 29256923 | 📋 | Cannabinoids for the Treatment of Neuropsychiatric Symptoms, Pain and Weight Loss in Dementia |
| Cannabidiol | Dementia | 2 | PM | 27567873 | 📋 | Delineating the Efficacy of a Cannabis-Based Medicine at Advanced Stages of Dementia in a Murine Model |
| Cannabidiol | Dementia | 4 | PM | 27110749 | 📋 | Natural Phytochemicals in the Treatment and Prevention of Dementia: An Overview |
| Cannabidiol | Dementia | 1 | PM | 16521031 | 📋 | Delta-9-tetrahydrocannabinol for Nighttime Agitation in Severe Dementia |
| Cannabidiol | Frontotemporal Dementia | 1 | PM | 35202719 | 📋 | Cannabidiol (CBD) treatment improves spatial memory in 14-month-old female TAU58/2 transgenic mice |
| Cannabidiol | Parkinson's Disease | 28 | PM | 38770713 | 📋 | Cannabidiol improves nonmotor symptoms, attenuates neuroinflammation and favors hippocampal newborn neuronal maturation in a rat model of Parkinsonism |
| Cannabidiol | Parkinson's Disease | 27 | PM | 38477419 | 📋 | Therapeutic applicability of cannabidiol and other phytocannabinoids in epilepsy, multiple sclerosis and Parkinson's disease and in comorbidity with psychiatric disorders |
| Cannabidiol | Parkinson's Disease | 26 | PM | 37220279 | 📋 | Cannabidiol Protects Dopaminergic-like Neurons against Paraquat- and Maneb-Induced Cell Death through Safeguarding DJ-1CYS106 and Caspase 3 Independently of Cannabinoid Receptors: Relevance in Parkinson's Disease |
| Cannabidiol | Parkinson's Disease | 25 | PM | 36964823 | 📋 | Cannabidiol Recovers Dopaminergic Neuronal Damage Induced by Reserpine or α-synuclein in Caenorhabditis elegans |
| Cannabidiol | Parkinson's Disease | 24 | PM | 36871008 | 📋 | Cannabidiol improves haloperidol-induced motor dysfunction in zebrafish: a comparative study with a dopamine activating drug |
| Cannabidiol | Parkinson's Disease | 23 | PM | 36108815 | 📋 | Neuroprotective effects of Cannabidiol on Dopaminergic Neurodegeneration and α-synuclein Accumulation in C. elegans Models of Parkinson's disease |
| Cannabidiol | Parkinson's Disease | 22 | PM | 35792194 | 📋 | Cannabidiol alleviates the damage to dopaminergic neurons in MPTP-induced Parkinson's disease mice via regulating neuronal apoptosis and neuroinflammation |
| Cannabidiol | Parkinson's Disease | 21 | PM | 35360659 | 📋 | Effects of Cannabidiol on Parkinson's Disease in a Transgenic Mouse Model by Gut-Brain Metabolic Analysis |
| Cannabidiol | Parkinson's Disease | 20 | PM | 34445626 | 📋 | Neuroprotective and Symptomatic Effects of Cannabidiol in an Animal Model of Parkinson's Disease |
| Cannabidiol | Parkinson's Disease | 19 | PM | 34246682 | 📋 | Cannabidiol has therapeutic potential for myofascial pain in female and male parkinsonian rats |
| Cannabidiol | Parkinson's Disease | 18 | PM | 33859553 | 📋 | Cannabidiol Induces Autophagy to Protects Neural Cells From Mitochondrial Dysfunction by Upregulating SIRT1 to Inhibits NF-κB and NOTCH Pathways |
| Cannabidiol | Parkinson's Disease | 17 | PM | 33848261 | 📋 | Potential role of cannabidiol in Parkinson's disease by targeting the WNT/β-catenin pathway, oxidative stress and inflammation |
| Cannabidiol | Parkinson's Disease | 16 | PM | 33381646 | 📋 | Safety and Tolerability of Cannabidiol in Parkinson Disease: An Open Label, Dose-Escalation Study |
| Cannabidiol | Parkinson's Disease | 15 | PM | 33333525 | 📋 | A Review of the Current Evidence Connecting Seborrheic Dermatitis and Parkinson's Disease and the Potential Role of Oral Cannabinoids |
| Cannabidiol | Parkinson's Disease | 12 | PM | 32210795 | 📋 | From Cannabis sativa to Cannabidiol: Promising Therapeutic Candidate for the Treatment of Neurodegenerative Diseases |
| Cannabidiol | Parkinson's Disease | 10 | PM | 32184097 | 📋 | Cannabidiol Exerts Protective Effects in an in Vitro Model of Parkinson's Disease Activating AKT/mTOR Pathway |
| Cannabidiol | Parkinson's Disease | 1 | PM | 31909680 | 📋 | Effects of Acute Cannabidiol Administration on Anxiety and Tremors Induced by a Simulated Public Speaking Test in Patients With Parkinson's Disease |
| Cannabidiol | Parkinson's Disease | 9 | PM | 31637586 | 📋 | Cannabidiol and Cannabinoid Compounds as Potential Strategies for Treating Parkinson's Disease and L-DOPA-Induced Dyskinesia |
| Cannabidiol | Parkinson's Disease | 13 | PM | 30706171 | 📋 | Is Cannabidiol the Ideal Drug to Treat Non-Motor Parkinson's Disease Symptoms? |
| Cannabidiol | Parkinson's Disease | 14 | PM | 28412918 | 📋 | Neurological Aspects of Medical Use of Cannabidiol |
| Cannabidiol | Parkinson's Disease | 4 | PM | 27733830 | 📋 | Cannabidiol Prevents Motor and Cognitive Impairments Induced by Reserpine in Rats |
| Cannabidiol | Parkinson's Disease | 6 | PM | 27366949 | 📋 | Delta-9-tetrahydrocannabinol Protects Against MPP+ Toxicity in SH-SY5Y Cells by Restoring Proteins Involved in Mitochondrial Biogenesis |
| Cannabidiol | Parkinson's Disease | 11 | PM | 26556726 | 📋 | The Neuroprotection of Cannabidiol Against MPP⁺-induced Toxicity in PC12 Cells Involves trkA Receptors, Upregulation of Axonal and Synaptic Proteins, Neuritogenesis, and Might Be Relevant to Parkinson's Disease |
| Cannabidiol | Parkinson's Disease | 8 | PM | 25888232 | 📋 | Promising Cannabinoid-Based Therapies for Parkinson's Disease: Motor Symptoms to Neuroprotection |
| Cannabidiol | Parkinson's Disease | 3 | PM | 22236282 | 📋 | Δ⁹-tetrahydrocannabinol (Δ⁹-THC) Exerts a Direct Neuroprotective Effect in a Human Cell Culture Model of Parkinson's Disease |
| Cannabidiol | Parkinson's Disease | 5 | PM | 21323909 | 📋 | Symptom-relieving and Neuroprotective Effects of the Phytocannabinoid Δ⁹-THCV in Animal Models of Parkinson's Disease |
| Cannabidiol | Parkinson's Disease | 2 | PM | 18801821 | 📋 | Cannabidiol for the Treatment of Psychosis in Parkinson's Disease |
| Cannabidiol | Parkinson's Disease | 7 | PM | 15837565 | 📋 | Cannabinoids Provide Neuroprotection Against 6-hydroxydopamine Toxicity in Vivo and in Vitro: Relevance to Parkinson's Disease |
